Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B.
Wang W, Zhou X, Bian Y, Wang S, Chai Q, Guo Z, Wang Z, Zhu P, Peng H, Yan X, Li W, Fu YX, Zhu M.
Wang W, et al. Among authors: wang z, wang s.
Nat Nanotechnol. 2020 May;15(5):406-416. doi: 10.1038/s41565-020-0648-y. Epub 2020 Mar 2.
Nat Nanotechnol. 2020.
PMID: 32123380
Free PMC article.